colon adenocarcinoma (Cancer)
Information
- Disease name
- colon adenocarcinoma
- Disease ID
- DOID:234
- Description
- "A colon carcinoma that derives_from epithelial cells of glandular origin." [url:http\://en.wikipedia.org/wiki/Adenocarcinoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04068103 | Active, not recruiting | Phase 2/Phase 3 | Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery | December 16, 2019 | April 30, 2027 |
NCT03365882 | Active, not recruiting | Phase 2 | S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery | November 27, 2017 | November 20, 2024 |
NCT03436563 | Active, not recruiting | Phase 1/Phase 2 | M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability | March 7, 2018 | August 2023 |
NCT04963283 | Active, not recruiting | Phase 2 | Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer | June 23, 2021 | February 9, 2026 |
NCT02863107 | Active, not recruiting | Young-Onset Colorectal Cancer | June 7, 2012 | August 31, 2030 | |
NCT02912559 | Active, not recruiting | Phase 3 | Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair | October 16, 2017 | April 2, 2025 |
NCT03949777 | Completed | N/A | Validation of Aer-O-Scope Colonoscope System Cecal Intubation | January 6, 2020 | November 14, 2021 |
NCT04003181 | Completed | N/A | The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon | September 28, 2017 | May 26, 2021 |
NCT00096278 | Completed | Phase 3 | Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer | September 15, 2004 | December 31, 2012 |
NCT02127359 | Completed | Whole-Exome Sequencing (WES) of Cancer Patients | September 2012 | December 2019 | |
NCT02368886 | Completed | Phase 2 | Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer | March 27, 2015 | March 2, 2023 |
NCT02393755 | Completed | Phase 1/Phase 2 | Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer | May 8, 2015 | May 18, 2021 |
NCT02569723 | Completed | N/A | Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy | October 16, 2015 | April 4, 2020 |
NCT03871790 | Completed | Peptide-based Immunization for Colon- and and Pancreas-carcinoma | April 1, 2019 | August 31, 2022 | |
NCT04349384 | Completed | Audit of Surgery for Colorectal Cancer | January 1, 2018 | December 31, 2019 | |
NCT04526314 | Completed | Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older | January 1, 2018 | July 1, 2020 | |
NCT05872334 | Completed | N/A | The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery | June 1, 2021 | April 5, 2023 |
NCT06216405 | Completed | N/A | Performance of Artificial Intelligence in Colonoscopy for Right Colon Polyp Detection | January 20, 2022 | January 3, 2024 |
NCT06426927 | Not yet recruiting | N/A | PeLear CCC: Proyecto Latino Contra Cancer Colorectal | July 1, 2024 | December 30, 2024 |
NCT04920032 | Recruiting | Phase 1 | Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas | August 26, 2021 | December 31, 2025 |
NCT05710406 | Recruiting | Phase 2/Phase 3 | Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer | May 30, 2023 | August 2034 |
NCT05186116 | Recruiting | N/A | LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis | January 1, 2022 | January 1, 2032 |
NCT05482516 | Recruiting | Phase 3 | Evaluating Novel Therapies in ctDNA Positive GI Cancers | March 29, 2023 | December 2028 |
NCT05746195 | Recruiting | N/A | Optimization of Adaptive Text Messages for Cancer Survivors (OATS II) | November 3, 2023 | November 30, 2024 |
NCT06414304 | Recruiting | Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy | June 1, 2022 | July 2026 | |
NCT06017141 | Recruiting | Phase 2 | Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study | May 22, 2023 | May 22, 2026 |
NCT03015038 | Unknown status | Study of the Immune Response in Colon Adenocarcinoma | February 5, 2017 | February 2024 | |
NCT04475159 | Unknown status | Phase 2 | Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial | August 1, 2020 | August 1, 2023 |
NCT05422547 | Unknown status | Role of Immunoscore® in Stage II-III Colorectal Cancer | April 1, 2022 | December 30, 2023 | |
NCT04057274 | Unknown status | N/A | Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth | September 23, 2019 | September 30, 2020 |
NCT04863768 | Unknown status | Molecular Profiling of Colorectal Cancer | January 1, 2006 | September 2022 | |
NCT02575508 | Withdrawn | Phase 1/Phase 2 | Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer |
- Disase is a (Disease Ontology)
- DOID:1520
- Cross Reference ID (Disease Ontology)
- MESH:D003110
- Cross Reference ID (Disease Ontology)
- NCI:C4349
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:255082000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0338106
- Exact Synonym (Disease Ontology)
- adenocarcinoma of colon
- Exact Synonym (Disease Ontology)
- Colonic adenocarcinoma
- Disase Synonym (Disease Ontology)
- adenocarcinoma of the colon